Shane Davis, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 13040 State Route 12, Boonville, NY 13309 Phone: 315-358-4028 Fax: 315-358-4186 |
Dr. Elaine Marie Moore, DPT Physical Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 110 Ford St, Boonville, NY 13309 Phone: 315-942-9220 |
Shane Davis Physical Therapy Pc Physical Therapist Medicare: Medicare Enrolled Practice Location: 13040 State Route 12, Boonville, NY 13309 Phone: 315-358-4028 Fax: 315-358-4186 |
Sandra Patrick Beasock, P.T. Physical Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1591 Hines Rd, Boonville, NY 13309 Phone: 315-942-3101 |
News Archive
In the engaging, humorous, and very informative HANDS OFF MY BELLY!: THE PREGNANT WOMAN'S SURVIVAL GUIDE TO MYTHS, MOTHERS, AND MOODS (Prometheus Books, $18.00), Drs. Shawn A. Tassone and Kathryn M. Landherr-experienced obstetricians and gynecologists, a husband-and-wife team of physicians, and parents of four children-explore superstitions and myths surrounding pregnancy, from the most common to the most obscure.
BioPontis Alliance, LLC announced today that it has entered into an innovative strategic agreement with Merck (known outside the US and Canada as MSD) designed to bridge the gap between early academic discovery science and the development of medicines and technologies that impact human health. The announcement was made this week at the prestigious Partnering For Cures Conference that is convened annually for the purpose of forging strategic cross-sector collaborations.
NexMed, Inc., a specialty CRO and a developer of products based on the NexACT® technology, today announced that pre-clinical results from its research and development group at Bio-Quant successfully demonstrated the ability of the NexACT technology to deliver an oral formulation of Taxol® (paclitaxel) and to enhance the drug's bioavailability by approximately ten-fold through this oral administration. Taxol, a first line chemotherapy drug used to treat breast, lung and ovarian cancers, is currently administered through an intravenous infusion that can take up to 24 hours to complete.
For the first time, Fox Chase Cancer Center researchers have demonstrated the ability to extract RNA from formalin-fixed, paraffin-embedded tissue samples archived for up to five years. What's more, the technology used retrieves high-quality samples, allowing researchers to identify cancer-related genetic changes. Accepted as a "late-breaking" abstract, the research was presented today at the 95th Annual Meeting of the American Association for Cancer Research by Renata Coudry, M.D., a research pathologist at Fox Chase Cancer Center.
EKF Diagnostics, the global in vitro diagnostics company, announces that it has introduced one of the first tests to precisely measure levels of COVID-19 neutralizing antibodies in individuals.
› Verified 8 days ago